CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33383586.
- Also identified by DOI 10.1093/cid/ciaa1904 and PMC identifier 8492212.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/μL, and CD4 count at ART prescription increased from 160 to 364 cells/μL.
Medical subject headings
- Anti-HIV Agents
- HIV Infections